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Abstract 24 
Introduction: In the UK, colorectal cancer is the fourth most common cancer and the second 25 
most common cause of cancer death.  Surgery is the primary modality of treatment but is not 26 
without complications.  Post-operative complications have been linked to pre-operative of 27 
weight loss and loss of lean tissue, and also to obesity.  Given sex differences in body 28 
composition, an examination of body composition and post-operative complications may 29 
provide valuable information.  Therefore, the aim was to examine the relationship between 30 
male/ female body composition and post-operative complications in patients with operable 31 
colorectal cancer. 32 
Methods: Patients (n=741) undergoing operation for colorectal cancer were examined. Pre-33 
operative CT scans were used to define the muscle mass and quality, visceral obesity and 34 
subcutaneous adiposity. Post-operative complications, in particular, surgical site infection 35 
(SSI) and wound infection (WI) were considered as outcome measures.  36 
Results: Male patients with greater subcutaneous adiposity had higher risk of SSI and WI 37 
(p<0.01 and p<0.001 respectively).  On multivariate analysis, Postoperative Glasgow 38 
Prognostic Score (poGPS) on Day4 (OR 2.11, 95% CI 1.53 -2.92, P =0.001) laparoscopic 39 
surgery (OR 0.50, 95% CI 0.26-0.98, P =0.044) and subcutaneous adiposity (OR 2.71, 95% 40 
CI 1.26-5.82, P =0.011) remained significantly independently associated with overall SSI. 41 
Subcutaneous adiposity remained significantly independently associated with WI (OR 3.93, 42 
95% CI 1.33-11.57, P=0.013).  In female patients, however, no significant association was 43 
found between any body composition measure and complications. 44 
Conclusion:  This study showed that increased subcutaneous and visceral adiposity were 45 
associated with infective complications in male, but not female patients, after colorectal 46 
 3 
cancer surgery. Therefore, it is important that sex be taken into account when evaluating the 47 
potential impact of body composition on post-operative outcomes in patients undergoing 48 
surgery for colorectal cancer. 49 
 50 
Keywords: body composition, visceral obesity, sarcopenia, colorectal cancer, post-operative 51 
complication, surgical site infection, wound infection. 52 
53 
 4 
Introduction 54 
Colorectal cancer is a common cancer in the UK and a leading cause of cancer death 55 
worldwide(1). Although surgery is an important aspect of the treatment of colorectal cancer, 56 
large proportion of patients develop complications after surgery, in particular infective 57 
complications. Surgical site infection (SSI) accounts for approximately 20% of all cases (2). 58 
SSI has been defined by the Centre for Disease Control and Prevention (CDC) as a post-59 
operative infection within 30 days of surgery. SSIs includes wound infection (WI) and 60 
anastomotic leakage (AL) and it is a major burden to health services worldwide (3,4).    61 
There is good evidence that the post-operative systemic inflammatory response (SIR) is 62 
linked to the development of post-operative infective complications following colorectal 63 
cancer surgery. A post-operative systemic inflammation score was developed based on the 64 
combination of CRP and albumin level, termed the post-operative Glasgow Prognostic Score 65 
(poGPS).  Indeed, concentrations of C-reactive protein (CRP) above 150 mg/L and albumin 66 
levels below 25g/L on post-operative days 3 and 4 were consistently reported to be associated 67 
with post-operative infectious complications. (25). Furthermore, body mass index (BMI), in 68 
addition to tumour site, mGPS, and ASA grade influence the magnitude of the PoGPS on 69 
days 3 and 4 (25).  70 
Obesity is well-known risk factor for the development of colorectal cancer. (5). In fact, many 71 
patients on diagnosis are overweight or obese.  Furthermore, the development of infectious 72 
complications following colorectal cancer surgery is associated with obesity (26). A 73 
systematic review by Malietzis and coworkers in 2015 concluded that there was consistent 74 
evidence that visceral obesity was associated with an increased incidence of post-operative 75 
complications and poorer short-term recovery (7).  76 
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Most of the studies that investigated the role of body composition and colorectal cancer 77 
outcomes have used Computed tomography (CT) scans since it is part of their routine staging 78 
(6,7,8).  This technique is recognized to have good specificity and precision regarding body 79 
composition analysis (24).  However, given that body composition varies with gender, it is 80 
not clear what aspect of body composition underpins the relationship between obesity and 81 
post-operative complications.  Moreover, gender is associated with differences in survival 82 
(9).  However, to our knowledge, the relationship between body composition and post-83 
operative infective complications has not been previously examined according to gender.  84 
The aim of this study was to examine the relationship between body composition and post-85 
operative complications in male and female patients undergoing surgery for colorectal cancer. 86 
87 
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Patients and Methods 88 
 89 
Patients: 90 
 A complete cohort of all patients with colorectal cancer who underwent surgical 91 
resection with curative intent between March 2008 and June 2016 in a single centre were 92 
identified from a prospective electronic database. 93 
Those patients with a preoperative CT scan, recorded height and weight and reported post-94 
operative complication were included. ASA grading and pre-operative haematological and 95 
biochemical markers were recorded. All tumors were staged according to TNM 5th edition. 96 
Ethical approval was granted from the West of Scotland Research Ethics Committee.   97 
 98 
Methods: 99 
CT scans were obtained at single cross-sectional areas of third lumbar vertebrae 100 
(L3MA) (10).  Patients with scans were taken more than 3 months prior to tsurgery were 101 
excluded from the study. The median and range for the interval between CT scanning and 102 
operation was 0.91 months (0.03-2.83). Scans with missing region of interest were excluded 103 
from the study. Each image was analysed using a program (NIH Image J version 1.47, 104 
http://rsbweb.nih.gov/ij/) (10).  105 
The region of interest (ROI) measurements were taken of visceral fat (VFA), 106 
subcutaneous fat (SFA) (Figure 1), and skeletal muscle areas (SMA) (cm2) using standard 107 
Hounsfield Unit (HU) ranges (skeletal muscle -29 to +150, and adipose tissue -190 to -30) 108 
(Figure 2,3). These measurements were normalised for height2 to produce indices; total fat 109 
index (TFI, cm2/m2), subcutaneous fat index (SFI, cm2/m2), visceral fat index (VFI, cm2/m2), 110 
and skeletal muscle index (SMI, cm2/m2). From the same ROI skeletal muscle radiodensity 111 
(SMD, HU) was measured. 112 
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Visceral obesity was defined as VFA >160cm2 for men and >80cm2 for women (22). 113 
High subcutaneous fat index (SFI) was defined as >50.0 cm2 /m2 in men and >42.0 cm2 /m2 114 
in women (11). Sarcopenia was described by Caan and colleagues as an SMI<52.3 cm2/m2 if 115 
BMI<30kg/m2 and SMI<54.3 cm2/m2 if BMI>30kg/m2 in men and an SMI<38.6 cm2/m2 if 116 
BMI<30kg/m2 and an SMI<46.6 cm2/m2 if BMI>30kg/m2 in women (12). Myosteatosis was 117 
defined by SMD <41HU in patients with BMI <25kg/m2 and <33HU in patients with BMI 118 
>25kg/m2 (23).     119 
Measurements were performed by two individuals (RD) and (AA) and inter-rater 120 
reliability was assessed in 40 patient images by interaclass correlation coefficients (ICCC) 121 
(TFA ICCC = 1.000, SFA ICCC = 1.000, VFA ICCC = 1.000, SMA ICCC = 0.998, SMD 122 
ICCC = 0.972).  123 
BMI was classified: (underweight <20 kg/m2, normal weight 20- 24.9 kg/m2, overweight 25- 124 
29.9 kg/m2, obese >30 kg/m2) 125 
Serum CRP (mg/L) and albumin (g/L) concentrations were measured using an autoanalyzer 126 
(Architect; Abbot Diagnostics, Maidenhead, UK).  The mGPS was calculated as described 127 
previously (10).  Preoperative neutrophil lymphocyte ratio (NLR) was calculated and values 128 
>5 were considered high.  129 
Statistical analysis: 130 
Categorical variables were analysed using χ2 test for linear-by-linear association.  The 131 
factors likely to influence SSI and WI were analysed using univariate and multivariate 132 
logistic regression analysis. Those body composition variables found to be significantly 133 
associated with overall  SSI were entered into a multivariate model with other significant 134 
variables.  135 
P values less than 0.05 were considered statistically significant.  Statistical analysis was 136 
performed using SPSS software (Version 21.0. SPSS Inc., Chicago, IL, USA). 137 
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Results 140 
 141 
In total, 832 patients with colorectal cancer were identified, and of these 91 were 142 
excluded due to missing eligible CT scan or anthropometric data. A total of 741 patients (410 143 
males, 331 females) were analysed. 144 
A comparison of baseline clinicopathological characteristics, host SIR, body composition and 145 
postoperative complications between male and female patients is shown in Table 1. There 146 
were no differences in clinicopathological characteristics and the SIR between male and 147 
female patients; mGPS and NLR (p=0.919 and p= 0.096 respectively).  However, there were 148 
significant differences in body composition and in the development of post-operative 149 
complications.  Specifically, more males had low subcutaneous adiposity compared to 150 
females (25% and 10% respectively, p<0.001), males had more sarcopenia compared with 151 
females (59% and 47% respectively, p<0.001), and had more myopenic obesity compared 152 
with females (10% and 5% respectively, p<0.001). 153 
 154 
The relationship between body composition measures and complications in male patients is 155 
shown in Table 2.  Male patients with high subcutaneous adiposity had a higher SSI rate and 156 
WI rate compared with those with low subcutaneous adiposity (p<0.01 and p<0.001 157 
respectively). Male patients with visceral obesity had a higher SSI rate compared with those 158 
with no visceral obesity (23% and 12% respectively, p<0.01) and had a higher WI rate 159 
compared with male patients with no visceral obesity (16% and 6% respectively, p<0.01).  160 
The WI  rate in male patients with sarcopenia was less compared to those with no sarcopenia 161 
(9% and 19% respectively, p<0.01).   162 
 163 
In male patients, the independent association of visceral obesity, sarcopenia and 164 
subcutaneous obesity with the SSI rate and the WI rate was examined in a binary logistic 165 
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regression model (Table 3). On univariate analysis, age, TNM stage, PoGPS Day 3 and 166 
PoGPS Day 4, laparoscopic surgery, subcutaneous adiposity, visceral obesity and sarcopenia, 167 
were associated with SSI (P<0.10). On multivariate analysis, PoGPS Day4 (OR 2.11, 95% CI 168 
1.53 -2.92, P =0.001)  laparoscopic surgery (OR 0.50, 95% CI 0.26-0.98, P =0.044) and 169 
subcutaneous adiposity (OR 2.71, 95% CI 1.26-5.82, P =0.011) remained significantly 170 
independently associated with SSI. 171 
On univariate analysis, age, ASA grade, TNM stage, PoGPS Day 3 and PoGPS Day 4 172 
neoadjuvant therapy, laparoscopic surgery, subcutaneous adiposity, visceral obesity and 173 
sarcopenia, were associated with WI (P<0.10).  On multivariate analysis, age (OR 0.57, 95% 174 
CI 0.37-0.90, p=0.015), TNM stage (OR1.45, 95% CI 1.01-2.09, p=0.043)    PoGPS Day 175 
3(OR 1.56, 95% CI 1.05 to 2.33, P=0.026), and subcutaneous adiposity (OR 3.93, 95% CI 176 
1.33-11.57, P=0.013) remained significantly independently associated with WI.  177 
The relationship between measures of body composition and complications in female patients 178 
is shown in Table 4.  No significant association was found between any body composition 179 
measure and complications in female patients.The independed association between  body 180 
composition and surgical site infection and wound infection in female patients with colorectal 181 
cancer presented in Table 5 as supplementary material. 182 
 183 
 184 
 185 
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 186 
Discussion 187 
 188 
The results of this study clearly show that post-operative complication rate in obese 189 
patients with colorectal cancer was greater in males.  In particular, subcutaneous adiposity in 190 
male patients was significantly associated with the development of surgical site infections 191 
and wound infections while in female patients there was no significant association. Therefore, 192 
the detrimental effect of obesity on post-operative complications would appear to be largely 193 
confined to male patients.  This has implications for the post-operative management of obese 194 
patients with colorectal cancer. 195 
 196 
The findings of this study may help to explain previous reports in large cohort studies that 197 
have observed that the occurrence of surgical site infection following surgery in males was 198 
approximately twice that in females (14).  There are a number of potential mechanisms that 199 
may explain the consistent discrepancy in infective complication rates between males and 200 
females.  Firstly, it may be that the surgical stress response differs between males and 201 
females.  However, in the present study there was no significant difference in the magnitude 202 
of the post-operative systemic inflammatory response between male and female patients.  203 
Another plausible explanation is that sex hormones differently affect wound healing (14).  204 
However, in the present study being male or female per se was not associated with the 205 
development of infective complications.  It may be that the differential impact of obesity in 206 
male and female patients on surgical site infective complications is due to the different 207 
distribution of adipose tissue in women and men (16).  In particular, adipose tissue 208 
accumulate in the abdomen, the site of surgery in men, in contrast, in women the adipose 209 
tissue accumulate in thighs and hips.  Fuente-Martín et al, (2013) showed that these 210 
differences are not limited to the distribution and amount of fat tissue, but also the metabolic 211 
response and function of adipose tissue differs between male and female.  Specifically, males 212 
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had increased proinflammatory immune cells in subcutaneous adipose tissue. They also have 213 
greater macrophage infiltration of subcutaneous adipose tissue (16).  Indeed, BMI defined 214 
obesity is independently associated with a greater magnitude of the post-operative SIR, 215 
(poGPS). Taken together these differences may result in males being more prone to post-216 
operative infective complications. 217 
 218 
 219 
Previous studies have linked skeletal muscle wasting with post-operative infection, high 220 
recurrence rates, and poorer outcomes in cases of colorectal cancer. (11,17,18).  Furthermore, 221 
Ebadi et al, (2017) reported that the longest survival was observed in sarcopenic patients with 222 
high subcutaneous adiposity (11). However, in our study we found that sarcopenic men had a 223 
lower wound infection rate, and this may be due to less subcutaneous fat tissue and therefore 224 
more favourable wound mechanics. Indeed, high subcutaneous adiposity at wound site has 225 
been reported to have reduced oxygenation compared with normal-weight patients, thus 226 
slowing the healing process and increasing susceptibility to infections (19). Decreased 227 
oxygen circulation increases the risk to surgical site infections, since wound healing requires 228 
high metabolic demands. In addition, immune cells have high oxygen demands, requiring 229 
oxygen for the formation of reactive oxygen species (20) 230 
 231 
 232 
The main limitation of this study that it was retrospective, with patients identified from the 233 
electronic database. Therefore, body composition analysis was carried out only on those 234 
patients that had height, weight and a pre-operative CT available for analysis.  A strength of 235 
the present study is that it is one of the largest studies to date examining the impact of body 236 
composition on post- operative outcomes in colorectal cancer.   237 
 238 
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In summary, the present study shows that obesity, in particular high subcutaneous adiposity 239 
and visceral obesity, was associated with the risk of SSI in men but not in women following 240 
colorectal cancer surgery.   This should be taken into account for obese men undergoing such 241 
surgery since it may impact on greater length of hospital stay and requirement for clinical 242 
resources.  243 
244 
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Figure legends 363 
Figure 1. Body composition profile on a CT image at level of L3 vertebra. Reproduced from 364 
(24) 365 
